Latest California Healthline Stories
The FDA authorized the emergency use of a one-shot vaccine made by Johnson & Johnson, which could help accelerate the pace of vaccinations to prevent covid-19. But after a dramatic decline, case numbers are again rising, and several states are rolling back public health mitigation efforts. Mary Ellen McIntire of CQ Roll Call, Joanne Kenen of Politico and Sarah Karlin-Smith of the Pink Sheet join KHN’s Julie Rovner to discuss these issues and more. Also this week, Rovner interviews KHN’s Jordan Rau about the latest KHN-NPR “Bill of the Month” episode.
As the speed of covid vaccinations picks up, so do the reports of doses going to waste. Health officials are trying to rein in waste without slowing down vaccinations.
Parents and caregivers of people with disabilities in California are supposed to be near the front of the line for the covid-19 vaccine. But some are hitting roadblocks at vaccination sites.
Aunque el gobierno los considera trabajadores de salud prioritarios, la confusión y la comunicación fallida han provocado que algunos padres elegibles sean rechazados.
Covid has pressed the Food and Drug Administration into its fastest vaccine reviews ever — which are still painfully slow, critics say.
The Trump and Biden administrations both imposed wartime production requirements. But industry experts say the vast quantities of raw materials and specialty equipment needed for billions of newfangled vaccines have required herculean logistical efforts.
Keeping a campaign promise, President Joe Biden has reopened enrollment for health coverage under the Affordable Care Act on healthcare.gov — and states that run their own health insurance marketplaces followed suit. At the same time, the Biden administration is moving to revoke the Trump administration’s permission for states to impose work requirements for some adults on the Medicaid health insurance program. Alice Miranda Ollstein of Politico, Kimberly Leonard of Business Insider and Rachel Cohrs of Stat join KHN’s Julie Rovner to discuss these issues and more. Also, Rovner interviews medical student Inam Sakinah, president of the new group Future Doctors in Politics.
Industry experts say it’s highly unlikely that dozens of pharmaceutical companies that aren’t already producing covid vaccines stand ready to do so.
The measures would impose taxes on increases in the price of drugs that don’t reflect improved clinical value and set the rates paid by state-run and commercial health plans to a benchmark based on prices in Canada.
Concerns arising in western North Carolina provide a window into the challenges facing health workers across the country as they seek to persuade vulnerable populations to be inoculated against covid.